Predictive factors for portal hypertension in patients with primary sclerosing cholangitis;Factores predictores de hipertensión portal en los enfermos con colangitis esclerosante primaria

Gastroenterologia y Hepatologia

Volumn 29, Issue 1, 2006, Pages 7-10

  Zapata Colindres, J C ^a   Montano Loza A ^a   Zepeda Gomez S ^a   Uscanga, L ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ASCITES; BLEEDING; CHEMICAL ANALYSIS; CLINICAL ARTICLE; COHORT ANALYSIS; DEMOGRAPHY; DIGESTIVE TRACT ENDOSCOPY; DISEASE ASSOCIATION; ESOPHAGUS VARICES; FEMALE; FOLLOW UP; HUMAN; HYPOALBUMINEMIA; LIVER DYSFUNCTION; LOGISTIC REGRESSION ANALYSIS; MALE; PORTAL HYPERTENSION; PRIMARY SCLEROSING CHOLANGITIS; RISK FACTOR; SPLENOMEGALY; THROMBOCYTOPENIA;

EID: 33644544131     PISSN: 02105705     EISSN: None     Source Type: Journal    
DOI: 10.1157/13083246     Document Type: Article

References (24)

1. Lay CS, Tsai YT, Teg C, Shyu WS, Guo WS, Wu KL, et al. Endoscopic variceal prophylaxis of first variceal bleeding in cirrhotic patients with high-risk esophageal varices. Hepatology. 1997;25:1346-50.
2. Poynard T, Cales P, Pasta L, Ideo G, Pascal JP, Pagliaro L, et al. Beta-adrenergic antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multicenter Study Group. N Engl J Med. 1991;324:1532-8.
3. Graham DY, Smith JL. The course of patients after variceal hemorrhage. Gastroenterology. 1981;80:800-9.
4. Pares A. Primary sclerosing cholangitis. Gastroenterol Hepatol. 2004;27:545-51.
5. Grace ND, Groszmann RJ, Garcia-Tsao G, Burroughs AK, Pagliaro L, Makuch RW, et al. Portal hypertension and variceal bleeding: an AASLD single topic symposium. Hepatology. 1998;28:868-80.
6. The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. N Engl J Med. 1988;319:983-9.
7. Zoli M, Merkel C, Magalotti D, Marchesini G, Gatta A, Pisi E. Evaluation of a new endoscopic index to predict first bleeding from the upper gastrointestinal tract in patients with cirrhosis. Hepatology. 1996;24:1047-52.
8. Jensen DM. Endoscopic screening for varices in cirrhosis: findings, implications, and outcomes. Gastroenterology. 2002;122L: 1620-30.
9. De Franchis R. Updating consensus in portal hypertension: report of the Baveno III consensus workshop on definitions, methodology, and therapeutic strategies in portal hypertension. J Hepatol. 2000;33:846-52.
10. Bressler B, Pinto R, El-Ashry D, Heathcote EJ. Which patients with primary biliary cirrhosis or primary sclerosing cholangitis should undergo endoscopic screening for oesophageal varices detection? Gut. 2005;54:407-10.
11. Adrover R, Cocozzella D, Borzi S, Montenegro L, Defelitto M, Bosia D, et al. When is the best time to perform upper digestive endoscopy to detect the presence of esophageal varices in patients with cirrhosis?. Gastroenterol Hepatol. 2004;27:353-6.
12. Angulo P, Lindor KD. Primary sclerosing cholangitis. Hepatology. 1999;30:325-32.
13. Wu CT, Davis PA, Luketic VA, Gershwin ME. A review of the physiological and immunological functions of biliary epithelial cells: targets for primary biliary cirrhosis, primary sclerosing cholangitis and drug-induced ductopenias. Clin Rev Immunol. 2004;11:205-13.
14. Portincasa P, Vacca M, Moschetta A, Petruzzelli M, Palasciano G, Van Erpecum KJ, et al. Primary sclerosing cholangitis: updates in diagnosis and therapy. World J Gastroenterol. 2005;11:7-16.
15. MacCarty RL, LaRusso NF, Wiesner RH, Ludwig J. Primary sclerosing cholangitis: findings on cholangiography and pancreatography. Radiology. 1983;149:39-44.
16. Japanese Research Society for Portal Hypertension. The general rules for recording endoscopic findings on esophageal varices. Jpn J Surg. 1980;10:84-7.
17. Ludwig J, LaRusso NF, Wiesner RH. Primary sclerosing cholangitis. En: Peters RL, Craig JG, editors. Contemporary issues in surgical pathology: liver pathology. New York: Churchill Livingstone, 1986. p. 193-213.
18. Angulo P, Larson DR, Therneau TM, LaRusso NF, Batts KP, Lindor KL. Time course of histological progression in primary sclerosing cholangitis. Am J Gastroenterol. 1999;94:3310-3.
19. Burak KW, Angulo PG, Lindor KD. Is there a role for liver biopsy in primary sclerosing cholangitis (PSC)? Am J Gastroenterol. 2003;98:1155-8.
20. Zein CO, Lindor KD, Angulo P. Prevalence and predictors of esophageal varices in patients with primary sclerosing cholangitis. Hepatology. 2004;39:204-10.
21. Zaman A, Becker T, Lapidus J, Benner K. Risk factors for the presence of varices in cirrhotic patients without a history of variceal hemorrhage. Arch Intern Med. 2001;161:2564-70.
22. Madhotra R, Mulcahy HE, Willner I, Reuben A. Prediction of esophageal varices in patients with cirrhosis. J Clin Gastroenterol. 2002;34:81-5.
23. Chalasani N, Imperiale TF, Ismail A, Sood G, Carey M, Wilcox CM, et al. Predictors of large esophageal varices in patients with cirrhosis. Am J Gastroenterol. 1999;94:3285-91.
24. Schepis F, Camma C, Niceforo D, Magnano A, Pallio S, Cinquegrani M, et al. Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection? Hepatology. 2001;22:333-8.